secwatch.observer — SEC 8-K summary
======================================

Issuer:     BECTON DICKINSON & CO (BDX)
CIK:        0000010795
Form:       8-K
Filed at:   2025-08-07T23:59:59+00:00
Accession:  0000010795-25-000069
Event type: earnings
Sentiment:  positive
Materiality: 0.80
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

BD Q3 revenue $5.5B (+10.4%); adjusted EPS $3.68; raises FY guidance to $14.30-$14.45
--------------------------------------------------------------------------------

- Revenue of $5.5B, up 10.4% as reported and 3.0% organic; GAAP EPS $2.00, adjusted EPS $3.68.
- GAAP gross margin up 160 bps; adjusted gross margin up 50 bps; GAAP operating income up 46.6%.
- Company raises full-year adjusted diluted EPS guidance to $14.30-$14.45 (up $0.18 at midpoint); reaffirms organic revenue growth guidance.
- Expects to complete remaining $250M of $1B share buyback commitment by end of fiscal 2025.
- In July, announced definitive agreement to combine BD's Biosciences & Diagnostic Solutions business with Waters Corporation.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/10795/000001079525000069/0000010795-25-000069-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/10795/000001079525000069/bdx-20250807.htm
  HTML page:      https://secwatch.observer/filing/0000010795-25-000069

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer